Cargando…

Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus

OBJECTIVES: The incidence of serious infections is poorly defined in patients with lupus nephritis (LN). It is also unclear if LN influences risk of serious infections in a longitudinal analysis. The aim of this study was to determine the incidence of serious infections in patients with SLE and LN,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, Drew Joseph, Mon, Saw Yu, Oh, Yumi, Okano, Satomi, Manickam, Valli, Soden, Muriel, Kubler, Paul, Ranganathan, Dwarakanathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509980/
https://www.ncbi.nlm.nih.gov/pubmed/32963113
http://dx.doi.org/10.1136/lupus-2020-000390
_version_ 1783585699076767744
author Yates, Drew Joseph
Mon, Saw Yu
Oh, Yumi
Okano, Satomi
Manickam, Valli
Soden, Muriel
Kubler, Paul
Ranganathan, Dwarakanathan
author_facet Yates, Drew Joseph
Mon, Saw Yu
Oh, Yumi
Okano, Satomi
Manickam, Valli
Soden, Muriel
Kubler, Paul
Ranganathan, Dwarakanathan
author_sort Yates, Drew Joseph
collection PubMed
description OBJECTIVES: The incidence of serious infections is poorly defined in patients with lupus nephritis (LN). It is also unclear if LN influences risk of serious infections in a longitudinal analysis. The aim of this study was to determine the incidence of serious infections in patients with SLE and LN, compared with patients with SLE without LN. METHODS: A multicentre retrospective cohort study was conducted. Patients with LN identified at two tertiary centres were matched where possible with age and gender-matched patients with SLE without LN. Any infection requiring inpatient admission, occurring in the 6 months following index clinical visit, was considered serious. Cox regression was employed to investigate the association between risk of serious infection and LN status, and other relevant covariates. RESULTS: A total of 173 patients were included within the analysis (n=87 LN, n=86 SLE only). A total of 9.2% (n=8) of patients with LN experienced at least one serious infection within the study period, compared with 5.8% (n=5) of patients without LN, equivalent to 19.5 and 12.0 infections per 100 patient-years with and without LN, respectively. Univariable and multivariable analyses found no significant increased risk of serious infection in patients with LN versus controls (HR 1.61; 95% CI 0.53 to 4.92 and adjusted HR (aHR) 0.91; 95% CI 0.27 to 3.06, respectively). Increased prednisone dose and modified SLE comorbidity index were strongly associated with serious infection (aHR (per 5 mg) 1.21; 95% CI 1.07 to 1.37; p=0.003 and aHR 1.13; 95% CI 1.02 to 1.25; p=0.018, respectively). CONCLUSIONS: In this cohort, adjusting for cofactors, the presence of LN alone does not appear to increase the risk of serious infections compared with patients with SLE without LN. However, increased prednisone dose at baseline visit and increasing comorbidity were independently associated with the incidence of serious infection.
format Online
Article
Text
id pubmed-7509980
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75099802020-10-05 Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus Yates, Drew Joseph Mon, Saw Yu Oh, Yumi Okano, Satomi Manickam, Valli Soden, Muriel Kubler, Paul Ranganathan, Dwarakanathan Lupus Sci Med Lupus Nephritis OBJECTIVES: The incidence of serious infections is poorly defined in patients with lupus nephritis (LN). It is also unclear if LN influences risk of serious infections in a longitudinal analysis. The aim of this study was to determine the incidence of serious infections in patients with SLE and LN, compared with patients with SLE without LN. METHODS: A multicentre retrospective cohort study was conducted. Patients with LN identified at two tertiary centres were matched where possible with age and gender-matched patients with SLE without LN. Any infection requiring inpatient admission, occurring in the 6 months following index clinical visit, was considered serious. Cox regression was employed to investigate the association between risk of serious infection and LN status, and other relevant covariates. RESULTS: A total of 173 patients were included within the analysis (n=87 LN, n=86 SLE only). A total of 9.2% (n=8) of patients with LN experienced at least one serious infection within the study period, compared with 5.8% (n=5) of patients without LN, equivalent to 19.5 and 12.0 infections per 100 patient-years with and without LN, respectively. Univariable and multivariable analyses found no significant increased risk of serious infection in patients with LN versus controls (HR 1.61; 95% CI 0.53 to 4.92 and adjusted HR (aHR) 0.91; 95% CI 0.27 to 3.06, respectively). Increased prednisone dose and modified SLE comorbidity index were strongly associated with serious infection (aHR (per 5 mg) 1.21; 95% CI 1.07 to 1.37; p=0.003 and aHR 1.13; 95% CI 1.02 to 1.25; p=0.018, respectively). CONCLUSIONS: In this cohort, adjusting for cofactors, the presence of LN alone does not appear to increase the risk of serious infections compared with patients with SLE without LN. However, increased prednisone dose at baseline visit and increasing comorbidity were independently associated with the incidence of serious infection. BMJ Publishing Group 2020-09-22 /pmc/articles/PMC7509980/ /pubmed/32963113 http://dx.doi.org/10.1136/lupus-2020-000390 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Lupus Nephritis
Yates, Drew Joseph
Mon, Saw Yu
Oh, Yumi
Okano, Satomi
Manickam, Valli
Soden, Muriel
Kubler, Paul
Ranganathan, Dwarakanathan
Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
title Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
title_full Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
title_fullStr Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
title_full_unstemmed Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
title_short Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
title_sort multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
topic Lupus Nephritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509980/
https://www.ncbi.nlm.nih.gov/pubmed/32963113
http://dx.doi.org/10.1136/lupus-2020-000390
work_keys_str_mv AT yatesdrewjoseph multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT monsawyu multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT ohyumi multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT okanosatomi multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT manickamvalli multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT sodenmuriel multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT kublerpaul multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus
AT ranganathandwarakanathan multicentreretrospectivecohortstudyassessingtheincidenceofseriousinfectionsinpatientswithlupusnephritiscomparedwithnonrenalsystemiclupuserythematosus